Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2005; 11(19): 2956-2959
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2956
Relationship between proliferative activity of cancer cells and clinicopathological factors in patients with esophageal squamous cell carcinoma
Jun-Xing Huang, Wei Yan, Zheng-Xiang Song, Rong-Yu Qian, Ping Chen, Eeva Salminen, Jorma Toppari
Jun-Xing Huang, Zheng-Xiang Song, Rong-Yu Qian, Ping Chen, Department of Oncology and Pathology, The People’s Hospital of Taizhou, Taizhou Medical School, Yangzhou University, Taizhou 225300, Jiangsu Province, China
Wei Yan, Department of Physiology and Cell Biology, University of Nevada, Reno Room 111, Anderson Building/352 1664 South Virginia Street, Reno, NV 89557, USA
Eeva Salminen, Department of Oncology, Turku University Hospital, Turku, Finland
Jorma Toppari, Department of Pediatrics and Physiology, University of Turku, FIN-20520 Turku, Finland
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Jun-Xing Huang, Department of Oncology and Pathology, The People’s Hospital of Taizhou, Taizhou 225300, Jiangsu Province, China. huangjunxing@yahoo.com.cn
Telephone: +86-523-6606300 Fax: +86-523-6225199
Received: June 15, 2004
Revised: June 16, 2004
Accepted: July 22, 2004
Published online: May 21, 2005
Abstract

AIM: To assess whether the molecular markers of malignant tumors could improve the understanding of tumor charact-eristics, and to observe the characteristics of expression of cell cycle markers Ki-67 and cyclin A in esophageal carcinoma and to analyze the relationship between proliferative activity of cancer cells and clinicopathological factors.

METHODS: Seventy of surgically resected esophageal squamous cell carcinoma (SCC) were examined by immun-ohistochemistry utilizing commercially available antibodies. Nuclear staining was regarded as a positive result. At least 50 fields in each tumor and non-tumor section were evaluated at a medium power (×200) to determine the proportion of tumor cells and the staining intensity of nuclei in the entire sections.

RESULTS: Ki-67 and cyclin A were only expressed in base cells of normal esophageal mucosa. The positive immuno-staining of nuclei of SCC was significantly higher than that in normal esophageal mucosa (t = 13.32 and t = 7.52, respectively, P<0.01). The distribution of positively stained was more diffuse and stronger in poorly differentiated SCC. Both Ki-67 and cyclin A expressions were related to histological grades of tumors (t = 3.5675 and t = 3.916; t = 2.13, respectively, P<0.05) but not to the sex and age of the patients, tumor size, lymphatic invasion, location, or stage grouping.

CONCLUSION: The proliferative activity of cancer cells may be understood by immunohistochemistry of Ki-67 and cyclin A in Chinese patients with esophageal SCC. These cell cycle markers may serve as an indicator of cancer cell proliferation rate. The overexpression of cell cycle markers Ki-67 and cyclin A suggests the poor SCC differentiation in patients with esophageal carcinoma.

Keywords: Proliferative activity, Esophageal neoplasms, Ki-67, Cyclin A